Dulaglutide promotes mitophagy by regulating copper metabolism and protects retinal pigment epithelial cells from high glucose-induced damage
Journal of the Renin-Angiotensin-Aldosterone System · 2026-02 · 27
DOI: 10.1177/14703203261426211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Renin-Angiotensin-Aldosterone System, online erschienen am 19.02.2026. Verfasst von Di Lu und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Chongqing Municipal Health Commission, Health Commission of Chengdu Municipality.
Abstract (Originalsprache)
Background
Copper metabolism dysregulation contributes to mitochondrial damage in diabetic retinopathy (DR). This study investigated whether dulaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, alleviates DR by regulating copper homeostasis.
Methods
Clinical serum analysis, high glucose-exposed ARPE-19 cells, and diabetic rat models were used. Measurements included copper/ceruloplasmin levels, oxidative stress, mitochondrial function, and mitophagy markers.
Results
Clinical test results show that the levels of ceruloplasmin and copper in the serum of patients with proliferative diabetic retinopathy (PDR) are significantly higher than those of diabetic patients. High glucose induced copper/ceruloplasmin accumulation, downregulated ATP7B/SOD1/COX11/ATP7A/CCS, upregulated SCO1/DMT1, and impaired mitochondrial function in retinal pigment epithelial (RPE) cells. Dulaglutide reversed these effects, reducing oxidative stress and inflammation while restoring mitochondrial integrity. Crucially, it activated PINK1/Parkin-mediated mitophagy. The protective effects were abolished by CuSO 4 , confirming copper homeostasis as central to its mechanism. In diabetic rats, dulaglutide corrected retinal copper metabolism abnormalities, ameliorated histopathological damage, and enhanced mitophagy, thereby preserving mitochondrial function and alleviating diabetic retinopathy.
Conclusion
Dulaglutide ameliorates DR by correcting copper dysregulation and promoting mitophagy, highlighting copper homeostasis as a potential therapeutic target.
Förderung
- Chongqing Municipal Health Commission
- Health Commission of Chengdu Municipality
Zitieren
APA
Lu, D., Li, Y., Shi, J., Yu, S., Wang, X., Liang, X., Mei, X., Wu, J., Chen, P., Huang, Q., & Liu, D. (2026). Dulaglutide promotes mitophagy by regulating copper metabolism and protects retinal pigment epithelial cells from high glucose-induced damage. Journal of the Renin-Angiotensin-Aldosterone System, 27. https://doi.org/10.1177/14703203261426211
Vancouver
Lu D, Li Y, Shi J, Yu S, Wang X, Liang X, et al. Dulaglutide promotes mitophagy by regulating copper metabolism and protects retinal pigment epithelial cells from high glucose-induced damage. Journal of the Renin-Angiotensin-Aldosterone System. 2026;27. doi:10.1177/14703203261426211
BibTeX
@article{Lu2026,
author = {Lu, Di and Li, Yao and Shi, Jiao and Yu, Simeng and Wang, Xiaoqin and Liang, Xinying and Mei, Xi and Wu, Juan and Chen, Peiyun and Huang, QIxuan and Liu, Dongfang},
title = {Dulaglutide promotes mitophagy by regulating copper metabolism and protects retinal pigment epithelial cells from high glucose-induced damage},
journal = {Journal of the Renin-Angiotensin-Aldosterone System},
year = {2026},
volume = {27},
doi = {10.1177/14703203261426211}
}
EUVIMED